BioSpace News Archive

Akero Therapeutics, Inc. announced the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA next week.

Relay Therapeutics announced that Sanjiv Patel, M.D., president and chief executive officer, is scheduled to present an overview of the company’s business and scientific objectives at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019 at 11:00 a.m. PT (2:00 p.m. ET).

PharmaExcipients China 2019 to Embark on a New Journey

Prof. Mario Sznol, Yale Cancer Center, Prof. David Hong, MD Anderson Cancer Center to join CAB

SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine.

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, today announced that it has extended its research collaboration with Sanofi initiated in late 2015 and Sanofi is investing* EUR 80 million (approximately USD 91.5 million) in equity in BioNTech.

Study to Explore Clinical Benefits of Precise, High Dose Radiation Therapy Enabled by MRIdian’s MR-guidance Combined with Daily On-table Adaptation in Pancreatic Cancer

The global tissue expanders market 2019-2023 is expected to post a CAGR of more than 5% during the forecast period, according to the latest market research report by Technavio.

Technavio analysts forecast the global hemorrhagic stroke treatment market to have an incremental growth of USD 162 million during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.

Comprised of an experienced leadership team, visionary investors, and renowned scientists in cell therapy, gene therapy, and gene editing